Electron microscopy showed similar morphological defects in both tubal and nasal mucosa.

Results: The expression level of miR-146a in AR nasal mucosa was significantly decreased.

Histopathological study performed on goat nasal mucosa revealed no adverse response of nanoparticles.

Cytokine concentrations in nasal mucosa were determined using the cytometric bead array method.

The nasal mucosa was infiltrated by eosinophic cells in all Ovalbumin immunized groups.

Intranasal midazolam was well tolerated but caused reversible irritation of the nasal mucosa.

Allergic nasal symptoms and eosinophil counts in nasal mucosa were measured.

In some cases the nasal mucosa becomes involved, resulting in chronic congestion and nosebleeds.

Methods: Human nasal mucosa was collected during sinus surgery and investigated in Ussing chambers.

Flunisolide seems to exert this effect through its antiinflammatory action on the nasal mucosa.

These results indicate that flunisolide can reduce the allergic inflammation of the nasal mucosa.

The stimulating electrodes were placed on the olfactory and respiratory regions of the nasal mucosa.

All cats had rhinitis, with or without intranuclear inclusion bodies in the nasal mucosa, and interstitial pneumonia.

There was a positive correlation between CD4+cell content in nasal mucosa and larger airways in asthmatics.

The nasal mucosa provides first line defense against inhaled pathogens while creating a unique microenvironment for bacterial communities.

CSs also can increase the transcription of the beta(2)-receptor gene in the lung and the nasal mucosa.